Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05137262
Title A PHASE II MULTICENTER STUDY OF CHEMOTHERAPY VERSUS CHEMOTHERAPY PLUS DURVALUMAB (MEDI 4736) IN PATIENTS WITH LYMPH NODE POSITIVE UROTHELIAL CARCINOMA OF THE BLADDER
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

bladder urothelial carcinoma

Therapies

Cisplatin + Doxorubicin + Durvalumab + Methotrexate + Vinblastine

Cisplatin + Doxorubicin + Methotrexate + Vinblastine

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.